Logo image of MBCN

MIDDLEFIELD BANC CORP (MBCN) Stock Fundamental Analysis

NASDAQ:MBCN - Nasdaq - US5963042040 - Common Stock - Currency: USD

29.76  +0.04 (+0.13%)

After market: 29.76 0 (0%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to MBCN. MBCN was compared to 396 industry peers in the Banks industry. While MBCN seems to be doing ok healthwise, there are quite some concerns on its profitability. While showing a medium growth rate, MBCN is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

MBCN had positive earnings in the past year.
In the past year MBCN had a positive cash flow from operations.
Each year in the past 5 years MBCN has been profitable.
Each year in the past 5 years MBCN had a positive operating cash flow.
MBCN Yearly Net Income VS EBIT VS OCF VS FCFMBCN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

1.2 Ratios

MBCN has a Return On Assets of 0.86%. This is comparable to the rest of the industry: MBCN outperforms 52.53% of its industry peers.
MBCN has a Return On Equity (7.57%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA 0.86%
ROE 7.57%
ROIC N/A
ROA(3y)0.91%
ROA(5y)0.94%
ROE(3y)7.91%
ROE(5y)8.47%
ROIC(3y)N/A
ROIC(5y)N/A
MBCN Yearly ROA, ROE, ROICMBCN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

1.3 Margins

With a Profit Margin value of 23.39%, MBCN perfoms like the industry average, outperforming 49.24% of the companies in the same industry.
In the last couple of years the Profit Margin of MBCN has declined.
The Operating Margin and Gross Margin are not available for MBCN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) 23.39%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-12.08%
PM growth 5Y-3.63%
GM growth 3YN/A
GM growth 5YN/A
MBCN Yearly Profit, Operating, Gross MarginsMBCN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

4

2. Health

2.1 Basic Checks

MBCN does not have a ROIC to compare to the WACC, probably because it is not profitable.
MBCN has less shares outstanding than it did 1 year ago.
The number of shares outstanding for MBCN has been increased compared to 5 years ago.
Compared to 1 year ago, MBCN has an improved debt to assets ratio.
MBCN Yearly Shares OutstandingMBCN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M
MBCN Yearly Total Debt VS Total AssetsMBCN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

The Debt to FCF ratio of MBCN is 0.61, which is an excellent value as it means it would take MBCN, only 0.61 years of fcf income to pay off all of its debts.
MBCN has a better Debt to FCF ratio (0.61) than 81.57% of its industry peers.
MBCN has a Debt/Equity ratio of 0.05. This is a healthy value indicating a solid balance between debt and equity.
MBCN has a better Debt to Equity ratio (0.05) than 80.05% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF 0.61
Altman-Z N/A
ROIC/WACCN/A
WACC14.15%
MBCN Yearly LT Debt VS Equity VS FCFMBCN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
MBCN Yearly Current Assets VS Current LiabilitesMBCN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

4

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 5.45% over the past year.
The Earnings Per Share has been growing slightly by 1.06% on average over the past years.
Looking at the last year, MBCN shows a decrease in Revenue. The Revenue has decreased by -1.85% in the last year.
The Revenue has been growing slightly by 7.99% on average over the past years.
EPS 1Y (TTM)5.45%
EPS 3Y-12.16%
EPS 5Y1.06%
EPS Q2Q%17.65%
Revenue 1Y (TTM)-1.85%
Revenue growth 3Y7.02%
Revenue growth 5Y7.99%
Sales Q2Q%7.62%

3.2 Future

MBCN is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 4.67% yearly.
MBCN is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.83% yearly.
EPS Next Y11.13%
EPS Next 2Y4.67%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year8.67%
Revenue Next 2Y6.83%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
MBCN Yearly Revenue VS EstimatesMBCN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 20M 40M 60M
MBCN Yearly EPS VS EstimatesMBCN Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 1 2 3

3

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 13.97 indicates a correct valuation of MBCN.
MBCN's Price/Earnings is on the same level as the industry average.
The average S&P500 Price/Earnings ratio is at 27.50. MBCN is valued slightly cheaper when compared to this.
A Price/Forward Earnings ratio of 13.32 indicates a correct valuation of MBCN.
MBCN's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. MBCN is more expensive than 69.95% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 36.44. MBCN is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 13.97
Fwd PE 13.32
MBCN Price Earnings VS Forward Price EarningsMBCN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

MBCN's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 12.6
EV/EBITDA N/A
MBCN Per share dataMBCN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20 25

4.3 Compensation for Growth

MBCN's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
PEG (NY)1.26
PEG (5Y)13.15
EPS Next 2Y4.67%
EPS Next 3YN/A

5

5. Dividend

5.1 Amount

MBCN has a Yearly Dividend Yield of 2.83%.
Compared to an average industry Dividend Yield of 3.25, MBCN has a dividend in line with its industry peers.
Compared to an average S&P500 Dividend Yield of 2.34, MBCN pays a bit more dividend than the S&P500 average.
Industry RankSector Rank
Dividend Yield 2.83%

5.2 History

On average, the dividend of MBCN grows each year by 6.90%, which is quite nice.
MBCN has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)6.9%
Div Incr Years0
Div Non Decr Years0
MBCN Yearly Dividends per shareMBCN Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

40.42% of the earnings are spent on dividend by MBCN. This is a bit on the high side, but may be sustainable.
The dividend of MBCN is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP40.42%
EPS Next 2Y4.67%
EPS Next 3YN/A
MBCN Yearly Income VS Free CF VS DividendMBCN Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
MBCN Dividend Payout.MBCN Dividend Payout, showing the Payout Ratio.MBCN Dividend Payout.PayoutRetained Earnings

MIDDLEFIELD BANC CORP

NASDAQ:MBCN (7/18/2025, 8:00:01 PM)

After market: 29.76 0 (0%)

29.76

+0.04 (+0.13%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)04-24 2025-04-24/amc
Earnings (Next)07-29 2025-07-29/bmo
Inst Owners26.86%
Inst Owner Change-1.62%
Ins Owners3.31%
Ins Owner Change0%
Market Cap240.46M
Analysts48.89
Price Target29.58 (-0.6%)
Short Float %0.9%
Short Ratio6.92
Dividend
Industry RankSector Rank
Dividend Yield 2.83%
Yearly Dividend0.8
Dividend Growth(5Y)6.9%
DP40.42%
Div Incr Years0
Div Non Decr Years0
Ex-Date05-30 2025-05-30 (0.21)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)28.26%
Min EPS beat(2)27.95%
Max EPS beat(2)28.58%
EPS beat(4)3
Avg EPS beat(4)18.02%
Min EPS beat(4)-11.17%
Max EPS beat(4)28.58%
EPS beat(8)4
Avg EPS beat(8)7.18%
EPS beat(12)8
Avg EPS beat(12)8.13%
EPS beat(16)12
Avg EPS beat(16)9.84%
Revenue beat(2)1
Avg Revenue beat(2)1.3%
Min Revenue beat(2)-0.04%
Max Revenue beat(2)2.64%
Revenue beat(4)1
Avg Revenue beat(4)-0.82%
Min Revenue beat(4)-3.78%
Max Revenue beat(4)2.64%
Revenue beat(8)2
Avg Revenue beat(8)-1.73%
Revenue beat(12)3
Avg Revenue beat(12)-1.65%
Revenue beat(16)4
Avg Revenue beat(16)-1.34%
PT rev (1m)2.35%
PT rev (3m)4.82%
EPS NQ rev (1m)0%
EPS NQ rev (3m)14.66%
EPS NY rev (1m)0%
EPS NY rev (3m)14.71%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)2.62%
Revenue NY rev (1m)0%
Revenue NY rev (3m)4.55%
Valuation
Industry RankSector Rank
PE 13.97
Fwd PE 13.32
P/S 3.48
P/FCF 12.6
P/OCF 11.99
P/B 1.12
P/tB 1.4
EV/EBITDA N/A
EPS(TTM)2.13
EY7.16%
EPS(NY)2.23
Fwd EY7.51%
FCF(TTM)2.36
FCFY7.94%
OCF(TTM)2.48
OCFY8.34%
SpS8.56
BVpS26.46
TBVpS21.3
PEG (NY)1.26
PEG (5Y)13.15
Profitability
Industry RankSector Rank
ROA 0.86%
ROE 7.57%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 23.39%
GM N/A
FCFM 27.6%
ROA(3y)0.91%
ROA(5y)0.94%
ROE(3y)7.91%
ROE(5y)8.47%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-12.08%
PM growth 5Y-3.63%
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF 0.61
Debt/EBITDA N/A
Cap/Depr 74.19%
Cap/Sales 1.38%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 117.97%
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score5
WACC14.15%
ROIC/WACCN/A
Cap/Depr(3y)67.12%
Cap/Depr(5y)54.69%
Cap/Sales(3y)1.4%
Cap/Sales(5y)1.5%
Profit Quality(3y)113.84%
Profit Quality(5y)117.74%
High Growth Momentum
Growth
EPS 1Y (TTM)5.45%
EPS 3Y-12.16%
EPS 5Y1.06%
EPS Q2Q%17.65%
EPS Next Y11.13%
EPS Next 2Y4.67%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-1.85%
Revenue growth 3Y7.02%
Revenue growth 5Y7.99%
Sales Q2Q%7.62%
Revenue Next Year8.67%
Revenue Next 2Y6.83%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-10.25%
FCF growth 3Y4.07%
FCF growth 5Y7.62%
OCF growth 1Y-10.26%
OCF growth 3Y4.24%
OCF growth 5Y5.35%